![BloodStream artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts123/v4/19/86/ba/1986ba60-84b2-4ee3-5c6c-e2f677b7ccdb/mza_5800774956923181338.png/100x100bb.jpg)
NBDF welcomes new CEO; HFA responds
BloodStream
English - February 09, 2024 08:00 - 28 minutes - 40.1 MB - ★★★★★ - 38 ratingsAlternative Health Health & Fitness advocacy biotech bleedingdisorders haemophilia healthcare hematology hemofilia hemophilia inhibitors insurance Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Preserving Tainted Blood History and Bath Bleeds
Next Episode: HFA CEO Dan Kelsey and Rare Disease Day tribute
NBFD landed a new CEO, and HFA has responded to recent organizational changes; plus, we hear from Dr. Mark Reding and Dr. Steven Pipe about their excitement over gene therapy being added to the treatment landscape in hemophilia. We close with @theHemeNP, Maya Bloomberg talkin’ Rare Disease Day.
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It’s a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media: